The United Kingdom Prospective Diabetes Study (UKPDS 49), demonstrated that long-term monotherapy with either insulin, sulfonylureas, or metformin could not sustain the glycemic control initially achieved (HbA1c <7%). The gene discussed is INS; the disease is diabetes mellitus.